{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:39:15Z","timestamp":1783651155807,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-025-04671-5","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:07:14Z","timestamp":1748509634000},"page":"158-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroprotective Potential of Chromium-D-Phenylalanine: Insights from Molecular Docking, Dynamics and Rotenone-Induced Parkinsonism in Rats"],"prefix":"10.1007","volume":"204","author":[{"given":"K. N.","family":"Anitha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mutahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivsharan B.","family":"Dhadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S.","family":"Gowrishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"4671_CR1","doi-asserted-by":"publisher","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","DOI":"10.3389\/fpubh.2021.776847"},{"issue":"1","key":"4671_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.37349\/ent.2023.00036","volume":"3","author":"K Radad","year":"2023","unstructured":"Radad K, Moldzio R, Krewenka C, Kranner B, Rausch W-D (2023) Pathophysiology of non-motor signs in Parkinson\u2019s disease: some recent updating with brief presentation. Explor Neuroprotective Ther 3(1):24\u201346","journal-title":"Explor Neuroprotective Ther"},{"issue":"1","key":"4671_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K et al (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4671_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):73","journal-title":"Signal Transduct Target Ther"},{"key":"4671_CR5","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Benito M, Granado N, Garc\u00eda-Sanz P, Michel A, Dumoulin M, Moratalla R (2020) Modeling Parkinson\u2019s disease with the Alpha-Synuclein protein. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.00356","DOI":"10.3389\/fphar.2020.00356"},{"issue":"16","key":"4671_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311(16):1670\u20131683","journal-title":"JAMA"},{"key":"4671_CR7","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357","journal-title":"Ageing Res Rev"},{"key":"4671_CR8","doi-asserted-by":"publisher","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V et al (2024) Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2024.10.004","DOI":"10.1016\/j.apsb.2024.10.004"},{"key":"4671_CR9","doi-asserted-by":"publisher","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S et al (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells 11(18). https:\/\/doi.org\/10.3390\/cells11182908","DOI":"10.3390\/cells11182908"},{"key":"4671_CR10","doi-asserted-by":"publisher","first-page":"105940","DOI":"10.1016\/j.nbd.2022.105940","volume":"176","author":"A Gopinath","year":"2023","unstructured":"Gopinath A, Mackie PM, Phan LT, Tansey MG, Khoshbouei H (2023) The complex role of inflammation and gliotransmitters in Parkinson\u2019s disease. Neurobiol Dis 176:105940","journal-title":"Neurobiol Dis"},{"key":"4671_CR11","doi-asserted-by":"publisher","first-page":"126879","DOI":"10.1016\/j.jtemb.2021.126879","volume":"69","author":"M Morvaridzadeh","year":"2022","unstructured":"Morvaridzadeh M, Est\u00eav\u00e3o MD, Qorbani M, Heydari H, Hosseini As, Fazelian S et al (2022) The effect of chromium intake on oxidative stress parameters: A systematic review and meta-analysis. J Trace Elem Med Biol 69:126879","journal-title":"J Trace Elem Med Biol"},{"key":"4671_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.biopha.2017.02.042","volume":"89","author":"S Nagarjun","year":"2017","unstructured":"Nagarjun S, Dhadde SB, Veerapur VP, Thippeswamy BS, Chandakavathe BN (2017) Ameliorative effect of chromium-d-phenylalanine complex on indomethacin-induced inflammatory bowel disease in rats. Biomed Pharmacother 89:1061\u20131066","journal-title":"Biomed Pharmacother"},{"key":"4671_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jinorgbio.2015.01.002","volume":"146","author":"M Peng","year":"2015","unstructured":"Peng M, Yang X (2015) Controlling diabetes by chromium complexes: the role of the ligands. J Inorg Biochem 146:97\u2013103","journal-title":"J Inorg Biochem"},{"key":"4671_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-444-64121-2.00002-7","volume-title":"The Nutritional Biochemistry of Chromium (III)","author":"HC Lukaski","year":"2019","unstructured":"Lukaski HC (2019) Chapter 2 - Effects of chromium(III) as a nutritional supplement. In: Vincent JB (ed) The Nutritional Biochemistry of Chromium (III), 2nd edn. Elsevier, pp 61\u201377","edition":"2"},{"key":"4671_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/B978-0-12-812019-4.00029-5","volume-title":"Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome","author":"JB Vincent","year":"2018","unstructured":"Vincent JB (2018) Chapter 29 - Beneficial Effects of Chromium(III) and Vanadium Supplements in Diabetes. In: Bagchi D, Nair S (eds) Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome, 2nd edn. Academic Press, pp 365\u2013374","edition":"2"},{"key":"4671_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jtemb.2014.06.014","volume":"29","author":"VK Dubey","year":"2015","unstructured":"Dubey VK, Ansari F, Vohora D, Khanam R (2015) Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. J Trace Elem Med Biol 29:222\u2013226","journal-title":"J Trace Elem Med Biol"},{"issue":"2","key":"4671_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1742-7843.2006.pto_288.x","volume":"98","author":"R Khanam","year":"2006","unstructured":"Khanam R, Pillai KK (2006) Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels. Basic Clin Pharmacol Toxicol 98(2):155\u2013159","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"4671_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1179\/147683010X12611460764084","volume":"13","author":"R Krikorian","year":"2010","unstructured":"Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD (2010) Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci 13(3):116\u2013122","journal-title":"Nutr Neurosci"},{"issue":"1","key":"4671_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10534-024-00656-4","volume":"38","author":"SB Dhadde","year":"2025","unstructured":"Dhadde SB, Kalshetti MS (2025) Chromium-histidine complex enhances reproductive physiology and development in Drosophila melanogaster by modulating oxidative stress. Biometals 38(1):321\u2013335","journal-title":"Biometals"},{"key":"4671_CR20","doi-asserted-by":"publisher","first-page":"1258081","DOI":"10.3389\/fphar.2023.1258081","volume":"14","author":"SB Dhadde","year":"2023","unstructured":"Dhadde SB, Kalshetti MS, Thippeswamy BS (2023) Synthesis of chromium-D-phenylalanine complex and exploring its effects on reproduction and development in Drosophila melanogaster. Front Pharmacol 14:1258081","journal-title":"Front Pharmacol"},{"key":"4671_CR21","doi-asserted-by":"publisher","unstructured":"Anitha KN, Darshan MC, Dhadde SB (2025) Trace element chromium-d-phenylalanine complex: anti-inflammatory and antioxidant insights from In Vivo and In Silico studies. Biol Trace Elem Res. https:\/\/doi.org\/10.1007\/s12011-025-04537-w","DOI":"10.1007\/s12011-025-04537-w"},{"issue":"5","key":"4671_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/01.STR.0000125722.10606.07","volume":"35","author":"T Kagiyama","year":"2004","unstructured":"Kagiyama T, Glushakov AV, Sumners C, Roose B, Dennis DM, Phillips MI et al (2004) Neuroprotective action of halogenated derivatives of L-phenylalanine. Stroke 35(5):1192\u20131196","journal-title":"Stroke"},{"issue":"3","key":"4671_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13596-012-0075-1","volume":"12","author":"N Sharma","year":"2012","unstructured":"Sharma N, Bafna P (2012) Effect of Cynodon dactylon on rotenone induced Parkinson\u2019s disease. Orient Pharm Exp Med 12(3):167\u2013175","journal-title":"Orient Pharm Exp Med"},{"key":"4671_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","volume":"1655","author":"ZN Zhang","year":"2017","unstructured":"Zhang ZN, Zhang JS, Xiang J, Yu ZH, Zhang W, Cai M et al (2017) Subcutaneous rotenone rat model of Parkinson\u2019s disease: Dose exploration study. Brain Res 1655:104\u2013113","journal-title":"Brain Res"},{"key":"4671_CR25","doi-asserted-by":"publisher","unstructured":"Garabadu D, Agrawal N (2020) Naringin exhibits neuroprotection against rotenone-induced neurotoxicity in experimental rodents. NeuroMol Med 1\u201317. https:\/\/doi.org\/10.1007\/s12017-019-08590-2","DOI":"10.1007\/s12017-019-08590-2"},{"key":"4671_CR26","first-page":"1","volume-title":"xPharm: The Comprehensive Pharmacology Reference","author":"M Williams","year":"2007","unstructured":"Williams M, Porsolt RD (2007) CNS Safety Pharmacology. In: Enna SJ, Bylund DB (eds) xPharm: The Comprehensive Pharmacology Reference. Elsevier, New York, pp 1\u201313"},{"issue":"3","key":"4671_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/JEnvironPatholToxicolOncol.v31.i3.30","volume":"31","author":"P Nagakannan","year":"2012","unstructured":"Nagakannan P, Shivasharan BD, Thippeswamy BS, Veerapur VP (2012) Restoration of brain antioxidant status by hydroalcoholic extract of Mimusops elengi flowers in rats treated with monosodium glutamate. J Environ Pathol Toxicol Oncol 31(3):213\u2013221","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"3","key":"4671_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12291-012-0256-1","volume":"28","author":"BD Shivasharan","year":"2013","unstructured":"Shivasharan BD, Nagakannan P, Thippeswamy BS, Veerapur VP (2013) Protective effect of calendula officinalis L flowers against monosodium glutamate induced oxidative stress and excitotoxic brain damage in rats. Indian J Clin Biochem 28(3):292\u2013298","journal-title":"Indian J Clin Biochem"},{"issue":"4","key":"4671_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bionut.2011.06.002","volume":"1","author":"VP Veerapur","year":"2011","unstructured":"Veerapur VP, Thippeswamy BS, Prabhakar KR, Nagakannan P, Shivasharan BD, Bansal P et al (2011) Antioxidant and renoprotective activities of Ficus racemosa Linn. stem bark: bioactivity guided fractionation study. Biomed Prev Nutr 1(4):273\u2013281","journal-title":"Biomed Prev Nutr"},{"issue":"1","key":"4671_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"4671_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","volume":"77","author":"SB Dhadde","year":"2016","unstructured":"Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP et al (2016) Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats. Biomed Pharmacother 77:52\u201358","journal-title":"Biomed Pharmacother"},{"key":"4671_CR32","doi-asserted-by":"publisher","unstructured":"Gelvan D, Saltman P (1990) Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay. Biochim Biophys Acta (BBA) Gen Sub 1035(3):353\u2013360. https:\/\/doi.org\/10.1016\/0304-4165(90)90100-b","DOI":"10.1016\/0304-4165(90)90100-b"},{"issue":"1","key":"4671_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1):131\u2013138","journal-title":"Anal Biochem"},{"key":"4671_CR34","first-page":"5499","volume":"9","author":"S Ojha","year":"2015","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME (2015) Neuroprotective potential of ferulic acid in the rotenone model of Parkinson\u2019s disease. Drug Des Devel Ther 9:5499\u20135510","journal-title":"Drug Des Devel Ther"},{"key":"4671_CR35","doi-asserted-by":"publisher","unstructured":"Duarte-Jurado AP, Gopar-Cuevas Y, Saucedo-Cardenas O, Loera-Arias MJ, Montes-de-Oca-Luna R, Garcia-Garcia A et al (2021) Antioxidant therapeutics in Parkinson\u2019s disease: current challenges and opportunities. Antioxidants (Basel) 10(3). https:\/\/doi.org\/10.3390\/antiox10030453","DOI":"10.3390\/antiox10030453"},{"key":"4671_CR36","doi-asserted-by":"publisher","unstructured":"Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E et al (2020) Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol 11. https:\/\/doi.org\/10.3389\/fphys.2020.00694","DOI":"10.3389\/fphys.2020.00694"},{"issue":"7","key":"4671_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/cells8070760","volume":"8","author":"SU Rehman","year":"2019","unstructured":"Rehman SU, Ikram M, Ullah N, Alam SI, Park HY, Badshah H et al (2019) Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK\/CREB signaling. Cells 8(7):760","journal-title":"Cells"},{"key":"4671_CR38","doi-asserted-by":"publisher","unstructured":"Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR (2005) A double-blind, placebo-controlled, exploratory trial of chromium picolinate in a typical depression: effect on carbohydrate craving. J Psychiatr Pract 11(5). https:\/\/doi.org\/10.1097\/00131746-200509000-00004","DOI":"10.1097\/00131746-200509000-00004"},{"issue":"38","key":"4671_CR39","doi-asserted-by":"publisher","first-page":"60823","DOI":"10.18632\/oncotarget.11661","volume":"7","author":"J Liu","year":"2016","unstructured":"Liu J, Chen M, Wang X, Wang Y, Duan C, Gao G et al (2016) Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson\u2019s disease model. Oncotarget 7(38):60823\u201360843","journal-title":"Oncotarget"},{"key":"4671_CR40","doi-asserted-by":"publisher","unstructured":"Tong H, Zhang X, Meng X, Lu L, Mai D, Qu S (2018) Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models. Front Mol Neurosci 11. https:\/\/doi.org\/10.3389\/fnmol.2018.00165","DOI":"10.3389\/fnmol.2018.00165"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-025-04671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-025-04671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-025-04671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T04:55:00Z","timestamp":1769489700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-025-04671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["4671"],"URL":"https:\/\/doi.org\/10.1007\/s12011-025-04671-5","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}